Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
Sumel Ashique, Mithun Bhowmick, Radheshyam Pal, et al.
Advances in Cancer Biology - Metastasis (2024) Vol. 10, pp. 100114-100114
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Assessment of Anticancer Properties of Thai Plants
Bancha Yingngam
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 122-164
Closed Access | Times Cited: 13
Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition
Hyeonji Yoo, Yeon-Jin Kim, Jinseong Kim, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 3994-3994
Open Access | Times Cited: 5
Development of a versatile biomaterial of chitosan polymer/ginger (Zingiber officinale Roscoe) extract/ZnO bionanocomposite: physicochemical properties, antioxidant activity, and breast cancer therapy
Muthanna O. Hussein, Ahmed Saud Abdulhameed
Research on Chemical Intermediates (2025)
Closed Access
Cellular Systems for Colorectal Stem Cancer Cell Research
Tatyana A. Grigoreva, Daria N. Kindt, Aleksandra Sagaidak, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 170-170
Open Access
Plant-Derived Molecules Modulate Multidrug Resistance in Gastrointestinal Cancers: A Comprehensive Review
Gloria Perazzoli, Cristina Mesas, Francisco Quiñonero, et al.
Applied Sciences (2025) Vol. 15, Iss. 3, pp. 1125-1125
Open Access
Wnt Pathway-Targeted Therapy in Gastrointestinal Cancers: Integrating Benchside Insights with Bedside Applications
Ashok Kumar Nayak, Hannah Streiff, Iván González, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 178-178
Open Access
Undescribed diterpenes from Euphorbia mauritanica L. as modulators of the breast cancer resistance: Mechanistic and in silico studies
Ahmed F. Essa, Mai M. Elghonemy, Rehab F. Taher, et al.
Phytochemistry (2025), pp. 114418-114418
Closed Access
Inulin as a Natural Ingredient in Cosmetics and Personal Care Products
Praveen Halagali, Vamshi Krishna Tippavajhala, Mahalaxmi Rathnanand, et al.
(2025), pp. 137-146
Closed Access
Inhibiting HSP90 changes the expression pattern of PINK1 and BNIP3 and induces oxidative stress in colon cancer cells
Ejlal Abu‐El‐Rub, Ayman Alzu’bi, Fatimah Almahasneh, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Open Access
Melanocortin-4 Receptor Antagonism Inhibits Colorectal and Anaplastic Thyroid Cancer In Vitro and In Vivo
Arianna Bandini, Marta Banchi, Paola Orlandi, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1165-1165
Open Access
Chitosan-Coated Silver Nanourchins for Imatinib Mesylate Delivery: Biophysical Characterization, In-Silico Profiling, and Anti-Colon Cancer Efficacy
Sankha Bhattacharya, Aalind Joshi, Vishal Beldar, et al.
Molecular Pharmaceutics (2025)
Closed Access
A narrative review on the use of Green synthesized metallic nanoparticles for targeted cancer therapy
Prashant Kumar, Sumel Ashique, Himanshu Sharma, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108305-108305
Closed Access
Potential of capsaicin as a combinatorial agent to overcome chemoresistance and to improve outcomes of cancer therapy
Bethsebie Lalduhsaki Sailo, Anushka Garhwal, Abinash Mishra, et al.
Biochemical Pharmacology (2025), pp. 116828-116828
Open Access
Doxorubicin-Conjugated Terbium-Doped Carbon Dots for Site-Specific Colon Cancer Theranostics
Dhanavardhini Kalyanasundaram, P. Sagayaraj, Tiasha Dasgupta, et al.
ACS Applied Nano Materials (2025)
Closed Access
Evaluation of potential substrates and inhibitors of MRP2 transporter to predict effective combinatorial chemotherapeutic agents for treating MRP2-associated non-responsive colorectal cancer
Absarul Haque, Ghazanfar Ali Baig, Abdulelah Saleh Alshawli, et al.
Journal of King Saud University - Science (2025), pp. 1-11
Open Access
Chitosan and its derivatives: A novel approach to gut microbiota modulation and immune system enhancement
Great Iruoghene Edo, Alice Njolke Mafe, Ali B. M. Ali, et al.
International Journal of Biological Macromolecules (2024) Vol. 289, pp. 138633-138633
Closed Access | Times Cited: 4
An updated landscape on nanopharmaceutical delivery for mitigation of colon cancer
Maria Shahzad, Huma Hameed, Ayesha Amjad, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 2
Chitosan nanoparticles of imatinib mesylate coated with TPGS for the treatment of colon cancer: In-vivo & in-vitro studies
Darshan Bhirud, Sankha Bhattacharya, Harshvardhan Raval, et al.
Carbohydrate Polymers (2024) Vol. 348, pp. 122935-122935
Closed Access | Times Cited: 2
A critical review on exploring tumor Microenvironment's impacts on radioresistance
Mohammad Houshyari
Journal of Radiation Research and Applied Sciences (2024) Vol. 17, Iss. 2, pp. 100937-100937
Open Access | Times Cited: 1
Apoptotic effect of 5-fluorouracil-doxorubicin combination on colorectal cancer cell monolayers and spheroids
Sema Bilgin
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
New paradigms to break barriers in early cancer detection for improved prognosis and treatment outcomes
Irfan Ahmad, Saade Abdalkareem Jasim, Madan Kumar Sharma, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 8
Closed Access | Times Cited: 1
Targeting the gut and tumor microbiome in cancer resistance
Sona Ciernikova, Aneta Sevcikova, Michal Mego
AJP Cell Physiology (2024) Vol. 327, Iss. 6, pp. C1433-C1450
Closed Access | Times Cited: 1
Coptisine enhances the sensitivity of chemoresistant breast cancer cells by inhibiting the function and expression of ABC transporters
Safaa Yehia Eid
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models
Rita Sala, Hector Esquer, Timothy Kellett, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13160-13160
Open Access | Times Cited: 1
Intelligent Systems Based on Cyclodextrins for the Treatment of Breast Cancer
Adenia Mirela Alves Nunes, José de Oliveira Alves-Júnior, Valeria Springer, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 30, pp. 2345-2363
Closed Access
Page 1 - Next Page

Scroll to top